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Abstract
Background:  Intracranial  aneurysms  are  abnormal  dilations  of  the  cerebral  arteries  of  unknown
origin. However,  some  genes  have  been  linked  to  their  formation,  as  in  the  case  of  NOS3  gene
which encodes  the  endothelial  nitric  oxide  synthase  responsible  for  producing  nitric  oxide.  Sev-
eral polymorphisms  in  this  gene,  in  association  with  a  variable  number  tandem  repeat  located
in intron  4  from  eNOS4  gene,  can  inﬂuence  the  formation  of  aneurysms.  Therefore,  the  purpose
of this  study  is  to  determine  the  genotype  frequencies  of  eNOS3  and  eNOS4  genes,  and  their
relationship  with  intracranial  aneurysms.
Material  and  methods: A  prospective  case--control  study  was  performed  on  79  cases  with  rup-
tured intracranial  aneurysm  and  93  healthy  controls.  DNA  was  obtained  from  all  subjects  for
the study  of  the  eNOS3  and  eNOS4  genes  by  molecular  techniques.
Results:  The  GG  genotype  of  eNOS3  gene  showed  the  largest  number  of  patients  (n  =  29)  with  a
large aneurysm.  While  the  intracranial  aneurysms  of  medium  size  were  found  in  a  higher  per-
centage (50%)  in  patients  with  genotype  GT.  In  terms  of  patient  outcomes,  it  was  observed  that
those with  genotype  GG  had  the  highest  percentage  (43.13%)  recovery,  compared  to  genotype
GT (27.27%).
 Please cite this article as: García-Ortiz L, Gutiérrez-Salinas J, Guerrero-Mun˜iz S, Chima-Galán MC, Sánchez-Hernández J. Aneurismas
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Conclusions:  The  present  study  shows  that  there  is  a  tendency  of  an  association  between  geno-
types of  eNOS3  gene  with  the  mean  size  of  the  aneurysm,  as  well  as  clinical  sequelae  of  the
disease in  patients  with  intracranial  aneurysms.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Published  by  Masson  Doyma  México  S.A.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Aneurismas  intracraneales  y  su  comportamiento  clínico-genético
Resumen
Antecedentes:  Los  aneurismas  intracraneales  son  dilataciones  anormales  de  las  arterias  cere-
brales. La  etiología  es  desconocida,  sin  embargo  algunos  genes  se  han  relacionado  con  su
formación;  como  el  caso  del  gen  NOS3  que  codiﬁca  a  la  sintetasa  de  óxido  nítrico  endotelial
encargada  de  producir  óxido  nítrico.  Varios  polimorﬁsmos  en  este  gen  en  asociación  con  un
número variable  de  repeticiones  en  tándem  localizado  en  el  intrón  4  del  gen  eNOS4  pueden
incidir en  la  formación  de  aneurismas.  Por  eso,  la  ﬁnalidad  de  nuestro  estudio  es  conocer  las
frecuencias genotípicas  de  los  genes  eNOS3  y  eNOS4  y  su  relación  con  aneurismas  intracraneales.
Material y  métodos:  Se  realizó  un  estudio  prospectivo  de  casos  y  controles.  Se  estudiaron  79
casos con  aneurisma  intracraneal  roto  y  93  controles  sanos;  de  todos  se  obtuvo  DNA  para  el
estudio de  los  genes  eNOS3  y  eNOS4.
Resultados:  El  genotipo  GG  del  gen  eNOS3  mostró  el  mayor  número  de  pacientes  (n  =  29)  con
aneurisma  intracraneal  grande.  Mientras  que  los  de  taman˜o  mediano  se  encontraron  en  mayor
porcentaje  (50%)  en  pacientes  con  genotipo  GT.  En  cuanto  a  la  evolución  de  los  pacientes,
se observó  que  aquellos  con  genotipo  GG  presentaron  el  mayor  porcentaje  (43.13%)  de  recu-
peración, en  comparación  con  los  de  genotipo  GT  (27.27%).
Conclusiones:  Nuestro  estudio  demuestra  que  en  los  casos  con  aneurismas  intracraneales  existe
una tendencia  de  asociación  entre  los  genotipos  del  gen  eNOS3  con  el  promedio  del  taman˜o  del
aneurisma,  así  como  con  las  secuelas  clínicas  de  la  enfermedad.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este
es un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Aackground
ntracranial  aneurysms  form  part  of  the  group  of  cerebrovas-
ular  disorders,  and  are  deﬁned  as  abnormal  dilations  of  the
erebral  arteries,  generally  located  in  the  bifurcation  of  the
rteries  which  form  the  Circle  of  Willis.  The  incidence  in  the
eneral  population  is  2--8%.1--3
Depending  on  how  they  present,  intracranial  aneurysms
an  be  classiﬁed  as  unruptured,  which  in  most  cases  are
ncidental  ﬁndings  on  cerebral  angiography  for  a  differ-
nt  diagnostic  purpose,  or  at  autopsy1--3;  and  ruptured,
hich  usually  cause  a  subarachnoid  haemorrhage  with
anifestations  which  include:  intense  headache,  nausea,
omiting,  focal  neurological  deﬁcit,  and  loss  of  conscious-
ess,  amongst  others.4 The  mortality  rate  for  ruptured
ntracranial  aneurysms  is  high  (50%),  while  25%  will  suffer
ermanent  disability,  paralysis,  loss  of  speech,  vision  and
otor  coordination.1
To  date,  the  aetiology  of  intracranial  aneurysms  is
nknown.  However,  various  environmental  factors  are  asso-
iated,  such  as  smoking,  systemic  arterial  hypertension  and
lcoholism.3,4 Similarly,  genetic  factors  are  associated  with
 predisposition;  although  there  is  no  deﬁned  Mendelian
nheritance  pattern  for  this  disease,  epidemiological  studies
h
o
r
nemonstrate  higher  autosomal  transmission;  the  ﬁrst  degree
elatives  of  a  person  with  an  intracranial  aneurysm  have  a
--6  times  greater  risk  than  that  of  the  general  population.3,4
enetic  studies  also  show  potential  sites  of  susceptible
enes,  or  loci,  for  the  formation  of  intracranial  aneurysms;
owever,  in  many  populations  these  results  have  been  con-
radictory,  as  in  the  case  of  the  gene  which  codes  the  nitric
xide  synthase  enzyme  (NOS),  which  is  responsible  for  pro-
ucing  nitric  oxide.3,5--9
Endothelial  nitric  oxide  synthase  (eNOS)  is  one  of  the
 isoforms  of  NOS,  found  in  the  body  constitutively10;  the
igniﬁcance  of  the  production  of  nitric  oxide  synthase  by
NOS  is  that  it  is  the  most  powerful  endogenous  vasodilator
nown.10,11 eNOS  is  coded  by  the  NOS3  gene  and  is  expressed
rincipally  in  the  endothelial  cells.  Various  polymorphisms
n  the  gene  have  been  described  in  association  with  a  vari-
ble  number  tandem  repeat  (VNTR),  located  in  intron  4
n  the  eNOS4  gene,  which  might  affect  the  expression  of
he  enzyme,  and  alter  the  circulating  levels  of  nitric  oxide.
s  an  example,  it  is  known  that  eNOS  participates  in  both
aemodynamic  and  structural  functions,  and  its  absence
r  reduction  might  cause  the  vascular  wall  to  weaken  or
upture,  conditioning  susceptibility  to  the  formation  of  coro-
ary  and  cerebral  aneurysms.7,10,12--16
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Table  1  General  features  in  case  and  control  groups.
Variable  Case  Control  p
n  79  85
Age; years  (mean  ±  SD)  55.46  ±  12.86  35.94  ±  10.2  0.002*
Female/male  58/21  30/55  <  0.001**
Personal  background  (%)
Smoker  29.11  27.05
Alcoholism  12.66  21.17
Diabetes mellitus  27.84  5.88
Arterial hypertension  39.24  2.35  <  0.001**
Ruptured  intracranial  aneurysm,  n  (%) 79  (100)
Hunt and  Hess  Scale,  n  (%) I  42  (53.2)
II  10  (12.6)
III  19  (24.1)
IV  8  (10.1)
V  0  (0)
Fischer  Scale  I  33  (41.8)
II  10  (12.6)
III  10  (12.6)
IV  26  (33)
Treatment  Surgical  clamping  (100%)
SD, standard deviation.
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In  2008,  Özüm  et  al.14 reported  that  the  TT  genotype
of  the  eNOS3  gene  G894T  polymorphism  is  signiﬁcantly
frequent  in  patients  with  ruptured  intracranial  aneurysm
compared  with  the  healthy  population,  and  is  associated
with  a  risk  of  rupture  (p  <  0.05).  However,  other  authors  did
not  ﬁnd  this  same  association,  probably  due  to  the  ethnic
differences  in  the  genotype  distribution.14
Studies  oriented  towards  gaining  a  deeper  knowledge  of
human  variability  help  us  to  understand  the  genetic  struc-
ture  of  our  population,  compare  it  with  other  populations,
and  to  propose  new  techniques  for  diagnosis,  and  even  spe-
ciﬁc  treatments  aimed  at  stabilising  the  patient.
Over  the  past  decade  both  Mexico,  and  clinical  genetics
have  undergone  major  development,  which  coincides  in  part
with  the  changes  in  the  national  health  proﬁle.  Thus,  the
purpose  of  our  work  is  to  gain  an  understanding  of  the  geno-
type  frequencies  of  the  polymorphisms  of  the  eNOS3  and
eNOS4  genes,  and  their  relationship  with  ruptured  intracra-
nial  aneurysms  in  the  Mexican  population.
We  know  that  a  delay  in  the  diagnosis  of  an  intracranial
aneurysm  increases  the  risk  of  rebleed,  especially  if  more
than  6  h  have  passed  since  the  initial  haemorrhagic  event.
Early  intervention,  known  as  ‘‘haemorrhage  prevention’’,  is
the  best  strategy  to  reduce  the  incidence  and  prevalence  of
this  disorder.
Material and methodsA  prospective  case--control  study  was  undertaken,  evalu-
ated  and  approved  by  the  Research  and  Ethics  Committees
of  the  Centro  Médico  Nacional  ‘‘20  de  Noviembre’’
(CMN),  Instituto  de  Seguridad  y  Servicios  Sociales  de  los
a
b
a
arabajadores  del  Estado  (ISSSTE);  all  of  the  participants
igned  their  informed  consent.  A  total  of  172  patients,  of
hom  79  had  been  diagnosed  with  ruptured  intracranial
neurysm,  conﬁrmed  by  panangiography  with  digital  sub-
raction;  their  general  and  clinical  features  are  described  in
able  1. Ninety-three  individuals  were  included  as  control
rom  the  same  geographical  area,  selected  at  random  from
he  Blood  Bank;  their  clinical  history,  blood  count  and
lood  chemistry  were  taken,  and  a  physical  examination
erformed.  They  were  classed  as  healthy  if  they  met  the
equirements.  A  5  ml  venous  blood  sample  was  taken  from
ll  of  them  in  Vacutainer  blood  collection  tubes  with  EDTA
nticoagulant,  for  DNA  extraction  by  salting  out17 and
tored  at  −20 ◦C,  for  subsequent  use.
olymerase  chain  reaction--restriction  fragment
ength polymorphism
894T  polymorphism  of  the  eNOS3  gene  was  analysed
y  polymerase  chain  reaction--restriction  fragment  length
olymorphism.  The  DNA  was  used  as  a  template  at  a  concen-
ration  of  5  g/ml  per  sample.  Subsequently  it  was  ampliﬁed
sing  the  following  oligonucleotides:  5′ cat  gag  gct  cag  ccc
agaac  3′ and  5′ agt  caa  tcc  ctt  tgg  tgc  tca  c  3′.  The  poly-
erase  chain  reaction  (PCR)  test  used  the  following:  1.25  U
f  TaqDNA  polymerase  (Invitrogen®),  1×  buffer  reaction,
gCl2 3  mM,  dNTP’s  0.2  mM  and  oligonucleotides  10  M,  for
 reaction  total  of  25  l.  The  PCR  conditions  were  as  follows:
n  initial  cycle  of  denaturation  at  95 ◦C  for  7  min,  followed
y  35  ampliﬁcation  cycles  (denaturation  at  94 ◦C  for  30  s,
nnealing  at  57 ◦C  for  30  s,  extension  at  72 ◦C  for  30  s)  and
 ﬁnal  extension  step  at  72 ◦C  for  7  min.  A  7  l  aliquot  was
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Table  2  Distribution  of  genotypes  for  eNOS3  and  eNOS4  in  case  and  control  groups.
eNOS3  Genotypes
GG  GT  TT  P*
n  %  n  %  n  %
Case  51  64.56  22  27.84  6  7.59
Control 75  88.23 8  9.41  2  2.35  0.001
eNOS4 a/b  b/b
n  %  n  %
Case  5  6.33 74  93.67
Control  1  1.18 84  98.82 0.079
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* 2.
sed  to  detect  the  ﬁnal  PCR  product  from  206  base  pairs,  and
ubjected  to  horizontal  electrophoresis,  using  2%  agarose
tained  with  ethidium  bromide  as  a  medium.  The  rest  of  the
mplicon  was  directed  with  the  restriction  enzyme  Mbol  at
7 ◦C  for  4  h;  the  fragments  were  analysed  by  electrophoresis
n  2%  agarose  gels  stained  with  ethidium  bromide.
olymerase  chain  reaction
NTR  polymorphism  of  the  eNOS4  a/b  gene  was  detected  by
CR  using  genomic  DNA  (5  g/L)  as  a  template  ampliﬁed
ith  the  following  oligonucleotides:  5′ agg  ccc  tat  ggt  agt  gcc
tt  3′ and  5′ tct  ctt  agt  gct  gtg  gtc  at  3′.  The  general  condi-
ions  for  the  PCR  were:  1×  buffer  reaction,  2.5  mM  of  MgCl2,
.4  M  of  dNTP’s,  0.5  M  of  oligonucleotides  and  1.25  U  of
aqDNA  polymerase  for  a  ﬁnal  volume  of  25  L.  The  PCR
as  started  with  denaturation  for  4  min  at  95 ◦C,  followed
y  35  ampliﬁcation  cycles  (denaturation  at  94 ◦C  for  30  s,
nnealing  at  58 ◦C  for  30  s,  extension  at  72 ◦C  for  30  s)  and  a
nal  extension  step  at  72 ◦C  for  7  min.  VNTR  polymorphism
f  the  eNOS4  a/b  gene  was  analysed  by  electrophoresis  in
%  agarose  gels  stained  with  ethidium  bromide.
tatistical  analysis
he  information  was  gathered  using  Excel  software
Microsoft  Corporation,  USA).  Graph  Pad  Prism  V-4.00
GraphPad  Software,  San  Diego,  CA,  USA)  was  used  for  the
tatistical  calculations.  The  distribution  of  genotypes  was
etermined  in  each  polymorphism;  the  2 test  was  used  to
ompare  the  genotype  frequencies  between  cases  and  con-
rols;  the  Kruskal--Wallis  and  ANOVA  tests  were  used  to  study
he  association  of  genotypes  with  categorical  data.  In  all
ases  the  p  value  <  0.05  was  used  as  statistically  signiﬁcant.
indingshe  general  feature  of  the  cases  with  intracranial  aneurysms
nd  the  controls  included  in  our  study  (Table  1)  show  that
he  female:male  ratio  is  higher  in  the  case  group  compared
o  the  control  group  (p  <  0.001).  Furthermore,  with  regard  to
t
e
p
personal  pathological  background,  the  case  group  presented
 higher  percentage  of  patients  with  diabetes  mellitus  and
ystemic  arterial  hypertension,  the  latter  being  known  to
igniﬁcantly  increase  the  risk  of  a  ruptured  aneurysm.
Similarly,  the  distribution  of  the  genotypes  of  the  eNOS3
nd  eNOS4  genes  was  studied  in  both  the  case  group  and  the
ontrol  group  (Table  2).  In  the  eNOS3  gene  the  GG  genotype
as  observed  to  predominate  in  both  the  case  group,  and  the
ontrol  group  (64.56%  and  88.23%;  respectively);  while  the
T  genotype  presented  more  frequently  in  the  case  group
p  =  0.0012).  Furthermore,  the  a/b  and  b/b  genotypes  of
ene  eNOS4  showed  similar  proportions  in  each  study  group,
he  b/b  genotype  presenting  in  over  90%  in  both  the  case  and
he  control  group.
Due  to  the  distribution  of  the  genotypes  of  gene  eNOS3,
t  showed  greater  heterogeneity  in  the  case  group,  a  cor-
elation  was  made  between  genotypes  and  frequency  of
resentation  of  intracranial  aneurysm  according  to  its  size;
lassiﬁed  as  small  (<  5  mm),  medium  (6--9  mm)  and  large
>  10  mm)  (Table  3).  As  can  be  observed,  the  GG  genotype
howed  the  greater  amount  of  patients  (n  =  29)  with  a  large
neurysm;  however  the  TT  genotype  had  the  greater  per-
entage  (83.34%)  of  patients  with  this  type  of  aneurysm.
hereas  medium-sized  intracranial  aneurysms  were  the
ighest  percentage  (50%)  in  patients  with  GT  genotype.  This
eterogeneity  in  the  size  of  aneurysms  between  the  geno-
ypes  produced  a  signiﬁcant  tendency  (p  =  0.05)  between
hem.
Furthermore,  taking  into  account  the  size  in  millime-
res  of  each  aneurysm  for  each  genotype,  the  mean  size
f  the  aneurysm  was  calculated,  and  they  were  compared
ith  one  another  (Fig.  1).  As  can  be  seen,  the  GT  genotype
resents  the  lowest  mean  of  the  3  genotypes  (7.73  ±  0.76
s  9.81  ±  0.54;  and  7.73  ±  0.76  vs  12.5  ±  1.12;  for  GT  vs  GG
nd  GT  vs  TT;  respectively).
Taking  the  patients’  outcomes  during  their  hospitalisa-
ion  into  account  (death,  sequelae  or  recovery),  it  was
bserved  that  there  was  greater  heterogeneity  of  results
n  the  GG  and  GT  genotypes  (Table  4).  Thus  it  was  noted
hat  the  patients  with  GG  genotype  presented  the  high-
st  percentage  (43.13%)  of  recovery,  compared  to  the
atients  with  GT  genotype  (27.27%).  By  contrast,  the
atients  with  GT  genotype  presented  the  highest  percentage
Intracranial  aneurysms  471
Table  3  Distribution  of  the  size  of  the  aneurysms  according  to  the  genotypes  of  the  eNOS3  gene  in  cases  with  intracranial
aneurysms.
Size  Genotypes  P*
GG
n  (%)
GT
n  (%)
TT
n  (%)
Small  7  (13.72)  5  (22.72)  0
Medium 15  (29.41)  11  (50)  1  (16.66)
Large 29  (56.86)  6  (27.27)  5  (83.34)
Total 51 (100) 22  (100) 6  (100)  0.05
GG: guanine, guanine; GT: guanine, thymine; TT: thymine, thymine.
* Kruskal--Wallis test.
Table  4  Clinical  course  of  the  cases  with  intracranial  aneurysm  divided  by  genotype.
Variable Genotype  eNOS3  n  (%) P*
GG  GT  TT
Dead  9  (17.64)  1  (4.54)  2  (33.33)
With sequelae  20  (39.22)  15  (68.18)  2  (33.33)
Recovered  22  (43.13)  6  (27.27)  2  (33.33)  0.05
GG: guanine, guanine; GT: guanine, thymine; TT: thymine, thymine.
* ANOVA.
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the eNOS3  gene.
(68.18%)  of  sequelae  and  the  lowest  percentage  of  deaths
(4.54%).
Discussion
In  recent  years,  the  Mexican  Health  Secretary  has  reported
cardiovascular  and  cerebrovascular  disease  as  principal
causes  of  death  in  the  general  adult  population,  occupy-
ing  the  second  and  third  place  respectively.18 Currently,
there  are  no  serum  and/or  genetic  markers  in  Mexico  to
enable  us  to  identify  these  diseases  in  advance.  On  a
global  level,  various  groups  have  studied  genetic  markers
with  clinical  relevance  for  intracranial  aneurysms.6,19--21 This
research  indicates  that  the  presence  of  G894T  polymor-
phisms  of  the  eNOS3  gene,  and  VNTR  a/b  polymorphisms
of  the  eNOS4  gene  are  associated  with  the  development
of  intracranial  aneurysms,5,14 and  with  other  diseases  of
vascular-endothelial  tissue.16,22
c
a
i
pThe  presence  of  these  2  polymorphisms  was  studied  in
he  Caucasian  population  of  the  USA,  observing  a greater
requency  of  the  GT  genotype  of  the  G894T  polymorphism,
ollowed  by  the  GG  and  TT  genotypes,  whereas,  in  the  black
opulation  of  Colombia  the  GG  genotype  was  more  frequent,
ollowed  by  the  GT  and  TT  genotypes.12,23 The  latter  ﬁndings
ere  also  found  in  our  population.
In  the  case  of  the  VNTR  a/b  polymorphism,  the  Americans
nd  the  Colombians  had  a  greater  frequency  of  the  genotype
/b,  followed  by  the  genotypes  b/a  and  a/a.12,23
In  our  study,  the  b/b  genotype  also  presented  with
reater  frequency;  however,  we  had  no  case  with  a/a  geno-
ype.  This  discrepancy  in  the  distribution  of  the  genotypes
ould  be  attributed  to  ethnic  differences  which  should  be
aken  into  account  for  our  population,  because  ancestrally,
e  have  a  different  proportion  of  American  Indian,  European
nd  African  ethnicities.24,25
Song  et  al.5 recently  described  the  relationship  between
uptured  aneurysms  and  genotypes;  they  found  that  in
atients  with  intracranial  aneurysms,  the  heterozygous
enotype  was  associated  with  the  size  of  the  aneurysm
ompared  with  wild-type  homozygotes  and  mutant  homozy-
otes.  Our  data  show  that  the  patients  with  medium-sized
neurysms  and  GT  heterozygous  genotype  had  the  highest
ercentage  of  sequela  due  to  rupture  (68.18%)  compared  to
G  and  TT  homozygotes,  therefore  the  data  put  forward  by
ong  et  al.5 and  our  ﬁndings  indicate  that  genotypes  can  be
sed  to  predict  the  risk  of  the  disorder.
There  are  currently  few  publications  in  Mexico  which  link
olymorphisms  of  the  eNOS  gene  with  the  size,  location,  and
onsequent  rupture  of  aneurysms,  therefore  further  studies
re  necessary  to  complement,  conﬁrm  or  discount  our  ﬁnd-
ngs  to  provide  greater  evidence  of  the  usefulness  of  these
olymorphisms  in  our  population.
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onclusions
ur  study  demonstrated  that  ruptured  intracranial  aneurysm
ccur  more  frequently  in  women  with  a  mean  age  of  55,
nd  a  history  of  system  arterial  hypertension.  It  was  also
ound  that  there  is  a  signiﬁcant  tendency  between  the  G894T
olymorphisms  of  the  eNOS3  gene,  and  the  VNTR  polymor-
hisms  of  the  eNOS4  gene  with  the  size  and  clinical  course
f  intracranial  aneurysms,  and  therefore  the  eNOS  gene
ppears  to  play  an  important  role  in  the  pathogenesis  of
his  disease.
This  information  could  be  used  by  neurological  doctors
nd  neurosurgeons,  to  generally  anticipate  the  course  of
he  disorder,  and  help  to  optimise  the  management,  moni-
oring,  treatment  and  recovery  of  patients  with  intracranial
neurysms.
Therefore,  genetic  screening  for  individuals  at  high  risk,
nd  their  potential  complications  might  be  a  clinical  test
vailable  in  the  future.
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